Terfenadine treatment of fall hay fever

C. E. Buckley, E. Buchman, C. J. Falliers, A. T. Segal, D. G. Tinkelman, B. B. Wray, V. G. Butler, L. J. Wille, T. H. Tsai

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A double-blind, parallel, multicenter study was undertaken in 215 ragweed skin test positive-patients with fall hay fever. The patients were randomized and treated for seven days with either 60 mg terfenadine twice daily, morning and evening, and a placebo at noon, or with 4 mg chlorpheniramine or placebo three times daily. The severity of nasopharyngeal itching, sneezing, rhinorrhea, nasal congestion, and itchy, watery, red eyes was ranked daily by patients and evaluated before and after treatment by the physican investigators. The patients reported a significant reduction in symptoms within one day. The physician investigators detected moderate to complete relief of symptoms in a greater proportion of the patients treated with terfenadine (70%) and chlorpheniramine (73%) than in the placebo-treated patients (48%). The incidence of sedation with terfenadine treatment (2.5%) was not different from that with placebo (2.4%) and both were lower than with chlorpheniramine (7.6%). We conclude that terfenadine is as effective as chlorpheniramine for the treatment of fall hay fever and that, unlike chlorpheniramine, the incidence of sedation with terfenadine was not different from placebo.

Original languageEnglish (US)
Pages (from-to)123-128
Number of pages6
JournalAnnals of Allergy
Volume60
Issue number2
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Terfenadine
Seasonal Allergic Rhinitis
Chlorpheniramine
Placebos
Therapeutics
Research Personnel
Sneezing
Ambrosia
Incidence
Pruritus
Skin Tests
Nose
Multicenter Studies
Physicians

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Buckley, C. E., Buchman, E., Falliers, C. J., Segal, A. T., Tinkelman, D. G., Wray, B. B., ... Tsai, T. H. (1988). Terfenadine treatment of fall hay fever. Annals of Allergy, 60(2), 123-128.

Terfenadine treatment of fall hay fever. / Buckley, C. E.; Buchman, E.; Falliers, C. J.; Segal, A. T.; Tinkelman, D. G.; Wray, B. B.; Butler, V. G.; Wille, L. J.; Tsai, T. H.

In: Annals of Allergy, Vol. 60, No. 2, 01.01.1988, p. 123-128.

Research output: Contribution to journalArticle

Buckley, CE, Buchman, E, Falliers, CJ, Segal, AT, Tinkelman, DG, Wray, BB, Butler, VG, Wille, LJ & Tsai, TH 1988, 'Terfenadine treatment of fall hay fever', Annals of Allergy, vol. 60, no. 2, pp. 123-128.
Buckley CE, Buchman E, Falliers CJ, Segal AT, Tinkelman DG, Wray BB et al. Terfenadine treatment of fall hay fever. Annals of Allergy. 1988 Jan 1;60(2):123-128.
Buckley, C. E. ; Buchman, E. ; Falliers, C. J. ; Segal, A. T. ; Tinkelman, D. G. ; Wray, B. B. ; Butler, V. G. ; Wille, L. J. ; Tsai, T. H. / Terfenadine treatment of fall hay fever. In: Annals of Allergy. 1988 ; Vol. 60, No. 2. pp. 123-128.
@article{d1c2a4bedf394a0cba7568929994b95c,
title = "Terfenadine treatment of fall hay fever",
abstract = "A double-blind, parallel, multicenter study was undertaken in 215 ragweed skin test positive-patients with fall hay fever. The patients were randomized and treated for seven days with either 60 mg terfenadine twice daily, morning and evening, and a placebo at noon, or with 4 mg chlorpheniramine or placebo three times daily. The severity of nasopharyngeal itching, sneezing, rhinorrhea, nasal congestion, and itchy, watery, red eyes was ranked daily by patients and evaluated before and after treatment by the physican investigators. The patients reported a significant reduction in symptoms within one day. The physician investigators detected moderate to complete relief of symptoms in a greater proportion of the patients treated with terfenadine (70{\%}) and chlorpheniramine (73{\%}) than in the placebo-treated patients (48{\%}). The incidence of sedation with terfenadine treatment (2.5{\%}) was not different from that with placebo (2.4{\%}) and both were lower than with chlorpheniramine (7.6{\%}). We conclude that terfenadine is as effective as chlorpheniramine for the treatment of fall hay fever and that, unlike chlorpheniramine, the incidence of sedation with terfenadine was not different from placebo.",
author = "Buckley, {C. E.} and E. Buchman and Falliers, {C. J.} and Segal, {A. T.} and Tinkelman, {D. G.} and Wray, {B. B.} and Butler, {V. G.} and Wille, {L. J.} and Tsai, {T. H.}",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "60",
pages = "123--128",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "2",

}

TY - JOUR

T1 - Terfenadine treatment of fall hay fever

AU - Buckley, C. E.

AU - Buchman, E.

AU - Falliers, C. J.

AU - Segal, A. T.

AU - Tinkelman, D. G.

AU - Wray, B. B.

AU - Butler, V. G.

AU - Wille, L. J.

AU - Tsai, T. H.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - A double-blind, parallel, multicenter study was undertaken in 215 ragweed skin test positive-patients with fall hay fever. The patients were randomized and treated for seven days with either 60 mg terfenadine twice daily, morning and evening, and a placebo at noon, or with 4 mg chlorpheniramine or placebo three times daily. The severity of nasopharyngeal itching, sneezing, rhinorrhea, nasal congestion, and itchy, watery, red eyes was ranked daily by patients and evaluated before and after treatment by the physican investigators. The patients reported a significant reduction in symptoms within one day. The physician investigators detected moderate to complete relief of symptoms in a greater proportion of the patients treated with terfenadine (70%) and chlorpheniramine (73%) than in the placebo-treated patients (48%). The incidence of sedation with terfenadine treatment (2.5%) was not different from that with placebo (2.4%) and both were lower than with chlorpheniramine (7.6%). We conclude that terfenadine is as effective as chlorpheniramine for the treatment of fall hay fever and that, unlike chlorpheniramine, the incidence of sedation with terfenadine was not different from placebo.

AB - A double-blind, parallel, multicenter study was undertaken in 215 ragweed skin test positive-patients with fall hay fever. The patients were randomized and treated for seven days with either 60 mg terfenadine twice daily, morning and evening, and a placebo at noon, or with 4 mg chlorpheniramine or placebo three times daily. The severity of nasopharyngeal itching, sneezing, rhinorrhea, nasal congestion, and itchy, watery, red eyes was ranked daily by patients and evaluated before and after treatment by the physican investigators. The patients reported a significant reduction in symptoms within one day. The physician investigators detected moderate to complete relief of symptoms in a greater proportion of the patients treated with terfenadine (70%) and chlorpheniramine (73%) than in the placebo-treated patients (48%). The incidence of sedation with terfenadine treatment (2.5%) was not different from that with placebo (2.4%) and both were lower than with chlorpheniramine (7.6%). We conclude that terfenadine is as effective as chlorpheniramine for the treatment of fall hay fever and that, unlike chlorpheniramine, the incidence of sedation with terfenadine was not different from placebo.

UR - http://www.scopus.com/inward/record.url?scp=0023846110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023846110&partnerID=8YFLogxK

M3 - Article

C2 - 3124674

AN - SCOPUS:0023846110

VL - 60

SP - 123

EP - 128

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 2

ER -